ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2563

Immune Regulation By Migrating Mesenchymal Stem Cells Ameliorate Inflammatory Arthritis in Mice

Seung Min Jung, Yoojun Nam and Ji Hyeon Ju, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Animal models, Immune regulation, Mesenchymal stem cells, regulatory cells and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Mesenchymal stem cells (MSCs) function as immune regulators in inflammatory conditions. However, it is unclear how to control local inflammation by systemically administered MSCs. We aimed to evaluate the therapeutic effect of human MSCs on inflammatory arthritis and to delineate the underlying mechanisms. 

Methods: Mice with collagen antibody induced arthritis (CAIA) were intraperitoneally injected with human bone marrow-derived MSCs (5 x 106 cells/500 μl of PBS, two times at three-day interval) or control vehicle. The clinical score and histological features of tarsal joints were compared between two groups. The synovial and spleen tissues of CAIA mice were stained with human anti-nuclear antibody (ANA) to confirm the migration of injected human MSCs. After analysis of multiple cytokines on peritoneal cells, migration assay of MSCs was performed in the presence of SDF-1a and/or CCL5. We evaluated the effect of MSCs on induction of regulatory T cells by coculture system in vitro and mRNA profiling in vivo. 

Results: Treatment with human MSCs alleviated the joint inflammation of CAIA mice. The clinical score was consistently lower in mice injected with MSCs compared to control mice. Histological analysis also revealed the conserved articular structure by MSCs. The joints and spleens of CAIA mice treated with human MSCs were positively stained with human ANA, suggesting recruitment of MSCs to inflamed tissues. Peritoneal lavage cells in mice treated with MSCs expressed a higher level of SDF-1a and CCL5, known as chemoattractants. MSCs migrated more easily in the presence of SDF-1a and/or CCL5. The synovia and spleens of CAIA mice treated with MSCs showed the upregulated expression of FOXP3 mRNA, which was supported by enhanced differentiation into regulatory T cells in coculture of CD4+ T cells and MSCs. 

Conclusion: This study suggests that MSCs would directly induce the differentiation of regulatory T cells through migration into inflamed tissues. Systemic administration of MSCs can be a therapeutic option for rheumatoid arthritis.


Disclosure: S. M. Jung, None; Y. Nam, None; J. H. Ju, None.

To cite this abstract in AMA style:

Jung SM, Nam Y, Ju JH. Immune Regulation By Migrating Mesenchymal Stem Cells Ameliorate Inflammatory Arthritis in Mice [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/immune-regulation-by-migrating-mesenchymal-stem-cells-ameliorate-inflammatory-arthritis-in-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immune-regulation-by-migrating-mesenchymal-stem-cells-ameliorate-inflammatory-arthritis-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology